Fund shareholders of IN8BIO INC
ISIN US45674E2081 · United States · LEI 549300H68IVCRKSGSL94
- Fund shareholders
- 8
- Of which ETFs
- 0 8 other funds
- Value held
- 610.3K $
- Share of capital
- 5.0 % of 9.9M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 332,083 | 345.4K $ | 0.03 % | 3.37 % | as of Jul 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 88,865 | 125.3K $ | 0.00 % | 0.90 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 63,611 | 119K $ | 0.00 % | 0.65 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 8,320 | 15.6K $ | 0.08 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,040 | 3.8K $ | 0.02 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 567 | 1.1K $ | 0.01 % | as of May 31, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 200 | 282 $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0 | 0.5 $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.03 % | as of Jul 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 8 | 0 | 495,687 | +11.8 % |
| 2026Q2 | 8 | 0 | 443,254 | +20.5 % |
| 2026Q1 | 8 | 0 | 367,711 | +169.5 % |
| 2025Q4 | 8 | +5 | 136,445 | +5.1 % |
| 2025Q3 | 3 | 129,771 |
Institutional managers
19 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 944,319 | 1.4M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 914,531 | 1.4M $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 724,637 | 1.1M $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 663,412 | 981.9K $ | as of Mar 31, 2026 |
| BIOS Capital Management, LP | 167,805 | 248.4K $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 88,865 | 132K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 86,239 | 127.6K $ | as of Mar 31, 2026 |
| VANGUARD FIDUCIARY TRUST CO | 43,570 | 64.7K $ | as of Mar 31, 2026 |
| CAPTRUST FINANCIAL ADVISORS | 33,295 | 49.3K $ | as of Mar 31, 2026 |
| OPPENHEIMER & CO INC | 24,033 | 35.6K $ | as of Mar 31, 2026 |
| Texas Capital Bank Wealth Management Services Inc | 23,750 | 35.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 20,440 | 30.3K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 12,433 | 18.4K $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2,785 | 4.1K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,265 | 1.9K $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 768 | 1.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 480 | 710 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 84 | 124 $ | as of Mar 31, 2026 |
| Rockefeller Capital Management L.P. | 83 | 123 $ | as of Mar 31, 2026 |
Declared shareholders of IN8BIO INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| LYTTON LAURENCE W and 1 other | 9.99 % | 1,056,513 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of IN8BIO INC". https://titelia.com/en/stocks/in8bio-inc-US45674E2081